| Date Filed | Type | Description |
| 06/12/2023 |
SC 13G
| Artal International S.C.A. reports a 6.6% stake in Selecta Biosciences, Inc. |
| 03/31/2023 |
SC 13G
| Artal International S.C.A. reports a 6.1% stake in Harpoon Therapeutics, Inc. |
| 02/13/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/01/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 08/23/2022 |
SC 13G
| Artal International S.C.A. reports a 6.4% stake in Vigil Neuroscience, Inc. |
| 08/05/2022 |
SC 13G
| Artal International S.C.A. reports a 6% stake in AlloVir, Inc. |
| 06/24/2022 |
SC 13G/A
| Artal International S.C.A. reports a 19.4% stake in Scholar Rock Holding Corporation |
| 02/11/2022 |
SC 13G/A
| Artal International S.C.A. reports a 8.3% stake in SEER, INC. |
| 02/11/2022 |
SC 13G/A
| Artal International S.C.A. reports a 8.2% stake in BELLUS Health Inc. |
| 02/11/2022 |
SC 13G/A
| Artal International S.C.A. reports a 5.8% stake in IGM Biosciences, Inc. |
| 02/11/2022 |
SC 13G/A
| Artal International S.C.A. reports a 6.4% stake in Cyclerion Therapeutics, Inc. |
| 02/11/2022 |
SC 13G/A
| Artal International S.C.A. reports a 4.9% stake in Generation Bio Co. |
| 02/11/2022 |
SC 13G/A
| Artal International S.C.A. reports a 7% stake in Scholar Rock Holding Corporation |
| 02/11/2022 |
SC 13G/A
| Artal International S.C.A. reports a 4.5% stake in LEAP THERAPEUTICS, INC. |
| 02/11/2022 |
SC 13G/A
| Artal International S.C.A. reports a 4.3% stake in Morphic Holding, Inc. |
| 02/11/2022 |
SC 13G
| Artal International S.C.A. reports a 5.6% stake in Syros Pharmaceuticals, Inc. |
| 02/11/2022 |
SC 13G/A
| Artal International S.C.A. reports a 8.8% stake in NANOBIOTIX S.A. |
| 09/27/2021 |
SC 13G
| Artal International S.C.A. reports a 5.2% stake in IGM Biosciences, Inc. |
| 07/12/2021 |
SC 13G
| Artal International S.C.A. reports a 5.7% stake in Ambrx Biopharma Inc. |
| 04/15/2021 |
SC 13G
| Artal International S.C.A. reports a 5.6% stake in Achilles Therapeutics plc |
| 03/31/2021 |
SC 13G
| Artal International S.C.A. reports a 5.3% stake in NEXIMMUNE, INC. |
| 03/31/2021 |
SC 13G
| Artal International S.C.A. reports a 5.2% stake in Omega Alpha SPAC |
| 02/12/2021 |
SC 13G/A
| Artal International S.C.A. reports a 6.2% stake in Scholar Rock Holding Corporation |
| 02/12/2021 |
SC 13G/A
| Artal International S.C.A. reports a 10.9% stake in SEER, INC. |
| 02/12/2021 |
SC 13G/A
| Artal International S.C.A. reports a 5.9% stake in NANOBIOTIX S.A. |
| 02/12/2021 |
SC 13G/A
| Artal International S.C.A. reports a 5.3% stake in Morphic Holding, Inc. |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Artal International S.C.A. reports a 6% stake in Generation Bio Co. |
| 02/12/2021 |
SC 13G/A
| Artal International S.C.A. reports a 5.4% stake in Cyclerion Therapeutics, Inc. |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/29/2021 |
SC 13G
| Artal International S.C.A. reports a 9.7% stake in APTINYX INC. |
| 12/28/2020 |
SC 13G
| Artal International S.C.A. reports a 5.9% stake in NANOBIOTIX S.A. |
|